Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech deals
Biotech
Novo Nordisk signs $530M biobucks deal to sing in Korro's opera
Novo isn’t done with the RNA deals, this time penning a $530 million biobucks deal to work with Korro on two cardiometabolic-related targets.
James Waldron
Sep 16, 2024 9:40am
Eli Lilly jumps deeper into AI with $409M Genetic Leap deal
Sep 5, 2024 9:16am
Bayer pens $547M pact to push boundaries of noncoding RNA
Aug 28, 2024 9:00am
Biogen CEO said no risky deals in 2023. Now he’s ready to be bold
Aug 1, 2024 10:34am
Boehringer offers up to $1.3B for checkpoint inhibitor biotech
Jul 29, 2024 10:31am
Vertex mines for more gene editing riches with $15M Orum deal
Jul 16, 2024 7:00am
